Vit i l igo i s an acquired depigmentat ion disorder of the skin in which there is loss of epidermal melanocytes. The prevalence of vitiligo is approximately 0.1-2% worldwide. The precise pathogenesis of vitiligo remains subtle and is probably multifactorial 1. Treatment of vitiligo remains an interesting topic and many centers have been reported as having varying degrees of success. Medical th...

Vitiligo is a common acquired disease of pigment loss. Though various non-invasive treatments (including local immunosuppression, ultraviolet light irradiation, etc.), transplantation cultured autologous melanocytes as cell suspension an emerging choice. An epidermal graft about 1cm2 was obtained by suction blistering from the abdomen patient, then dissociated into single cells and in different...

BackgroundTopical calcineurin inhibitors are used off label in the treatment of vitiligo, and there is a lack placebo-controlled, blinded studies to support their use.ObjectiveThis study aimed compare efficacy tacrolimus 0.1% ointment with that vehicle for repigmentation adult patients facial vitiligo.DesignThis was 24-week multicenter randomized parallel double-blind post-treatment follow-up e...

There is widespread misinformation, taboos, and a lack of scientific analysis about vitiligo. In Bangladesh, there scarcity research on vitiligo, though advanced treatments are widely available. This study aimed to investigate the treatment efficacy vitiligo in selected dermatology clinic analyze factors that impact level. was an analytical cross-sectional among patients who attended for were f...

Vitiligo is an autoimmune skin disease mediated by autoreactive T cells that destroy epidermal melanocytes, causing depigmentation. Current treatments, e.g. corticosteroids or UV light therapy, have limited efficacy with inconsistent repigmentation in many patients. Some emerging therapies, JAK inhibitors, show promising activity but carry potential systemic safety risks. Tissue-restricted immu...

Background: Facial repigmentation is the main primary outcome measure of most trials assessing new treatments for vitiligo. Objective: To assess validity and reliability an objective measurement method percent depigmentation vitiligo lesions on face. Methods: Multicentric cross-sectional prospective trial. 22 consecutive patients presenting with facial were included. Depigmentation was analyzed...

Progressive Macular Hypomelanosis is often an underdiagnosed hypo pigmented, nonscaly, macular eruption involving the trunk, abdomen, face,extremities and the buttocks with great cosmetic concern to the sufferer. Topical antifungal, corticosteroid has been ineffective in its treatment but phototherapy and topical antimicrobial has proven effective over time. Objective: This study seeks to deter...